These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 4083230)
1. [Allergic manifestations of systemic lupus erythematosus]. Diumenjo MS; Lisanti M; Vallés R; Rivero I Allergol Immunopathol (Madr); 1985; 13(4):323-6. PubMed ID: 4083230 [TBL] [Abstract][Full Text] [Related]
2. Allergy and SLE: common and variable. Shahar E; Lorber M Isr J Med Sci; 1997 Feb; 33(2):147-9. PubMed ID: 9254878 [TBL] [Abstract][Full Text] [Related]
3. Frequency of adverse drug reactions in patients with systemic lupus erythematosus. Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805 [TBL] [Abstract][Full Text] [Related]
4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
5. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families. Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512 [TBL] [Abstract][Full Text] [Related]
6. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265 [TBL] [Abstract][Full Text] [Related]
7. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362 [TBL] [Abstract][Full Text] [Related]
8. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261 [TBL] [Abstract][Full Text] [Related]
9. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664 [TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic allergy in systemic lupus erythematosus: a case-control study. Petri M; Allbritton J J Rheumatol; 1992 Feb; 19(2):265-9. PubMed ID: 1629825 [TBL] [Abstract][Full Text] [Related]
13. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876 [TBL] [Abstract][Full Text] [Related]
14. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137 [TBL] [Abstract][Full Text] [Related]
15. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases. Půtová I; Dostal C; Becvar R Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316 [TBL] [Abstract][Full Text] [Related]
18. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242 [TBL] [Abstract][Full Text] [Related]
19. Chronic autoimmune urticaria as the first manifestation of juvenile systemic lupus erythematosus. Spadoni M; Jacob C; Aikawa N; Jesus A; Fomin A; Silva C Lupus; 2011 Jun; 20(7):763-6. PubMed ID: 21183563 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]